Molecules vs BioViewer Utilisation & Stats

Molecules is an application for viewing three-dimensional renderings of molecules and manipulating them using your fingers. You can rotate the molecules by moving your finger across the display, zoom in or out by using two-finger pinch gestures, or pan the molecule by moving two fingers across the screen at once. These structures can be viewed in both ball-and-stick and spacefilling visualization modes. Molecules can be stored on your handheld device for later viewing and are loaded via a standard document-based file browser. Custom molecular structures can be downloaded to the application via file sharing or iCloud, and obtained via sources like the RCSB Protein Data Bank (http://www.rcsb.org/pdb), an international repository of biological molecules and their 3-D structures, or NCBI's PubChem (http://pubchem.ncbi.nlm.nih.gov), a public database of compounds. For more details, please visit our website. Molecules is a BSD-licensed open source project.
  • Apple App Store
  • Gratuit
  • Éducation

Classement dans le store

- -

A .pdb protein visualizer for iOS, iPadOS and macOS. View the 3D representation of any molecular structure from a .pdb file, using our custom Metal-based rendering engine based to allow for a smooth experience even in the biggest proteins.  - Full drag and drop support for .pdb and .xyz files. - Photo Mode with publication-quality exports. - Support for multi-model PDBs. - Support for high refresh rate ProMotion displays.
  • Apple App Store
  • Gratuit
  • Éducation

Classement dans le store

- -

Comparaison des classements Molecules vs. BioViewer

Comparez l'évolution du classement de Molecules au cours des 28 derniers jours à celle de BioViewer.

Rank

Aucune donnée disponible

Comparaison des classements Molecules et BioViewer par pays

Comparez l'évolution du classement de Molecules au cours des 28 derniers jours à celle de BioViewer.

Aucune donnée à afficher

Comparez avec n'importe quel site grâce à notre essai gratuit

Démarrer
Molecules VS.
BioViewer

15écembre d, 2024